Finch Therapeutics Raises $36 Million Series B, Bringing Total to $77 Million Post author:Sam Post published:February 28, 2018 Post category:BioPharma Finch Therapeutics closed on an oversubscribed Series B financing worth $36 million. Source: BioSpace You Might Also Like Mayne Pharma Appoints Executive Vice President at Metrics Contract Services July 18, 2017 Bill Gates Makes Plea to Healthcare Capitalists, Biotechs to Help Change the World January 10, 2018 <b>Medical Device Innovation Consortium</b> Announces <b>Rachael L. Fleurence</b>, Ph.D. Appointed As Executive Director Of The <b>National Evaluation System For Health Technology Coordinating Center</b> (NESTcc) April 11, 2017
<b>Medical Device Innovation Consortium</b> Announces <b>Rachael L. Fleurence</b>, Ph.D. Appointed As Executive Director Of The <b>National Evaluation System For Health Technology Coordinating Center</b> (NESTcc) April 11, 2017
